bit bio


bit bio

Our breakthrough technology combines synthetic and stem cell biology, offering limitless possibilities. Enabling a new generation of cell therapies, providing the best human cells for research and drug discovery, and allowing the control of advanced synthetic biology circuits for biomanufacturing.

Contact bit bio via their website


News archive

20/05/2021   bit.bio looks to transform dementia treatments and grow organs to order...more
14/05/2021   bit.bio's Mark Kotter: "A single cell to feed the world"...more
26/04/2021   Read bit.bio CEO blogpost on why he started a healthcare and cultured meat company...more
21/04/2021   bit.bio - Inside the breakthrough taking lab-grown meat to the supermarket...more
16/04/2021   bit.bio wins Biotech Company of the Year...more
14/04/2021   Meet the company reprogramming the future of synthetic biology...more
09/04/2021   Sitting down with... bit.bio...more
07/04/2021   Pint of Science podcast mini-series: why bit.bio is 'coding cells for health' ...more
26/03/2021   bit.bio CEO speaks at TEDxCambridgeUniversity event...more
23/03/2021   Cultivated meat, cell therapies and opti-ox™ - as told by bit bio...more
11/02/2021   bit.bio Welcomes New Chief Medical Officer Ramy Ibrahim...more


13/11/2020   bit.bio published in Forbes...more
27/10/2020   bit.bio published in The Times...more
27/10/2020   bit.bio on a moonshot mission with London Institute for Mathematical Sciences...more
11/06/2020   bit bio secures $41.5m funding from top life sciences investors...more
26/02/2020   bit bio Secures Distribution Agreement with Abcam...more

11/12/2019   Charles River Announces Strategic Partnership with bit bio...more
01/12/2019   bit bio joins the BioPartner programme...more

The BioPartner Programme

BPP members enjoy our full range of discounts, enhanced promotion on BioPartner UK Delegations and first refusal on new international opportunities.

Not a member? Join the BioPartnership Programme

BioPartner UK is a member of

Sponsors Alliance

Prompt Payment Code